Status:
COMPLETED
Use of Lidocaine in Rapid Sequence Induction
Lead Sponsor:
University of Athens
Conditions:
Hemodynamic Response
Eligibility:
All Genders
20-70 years
Phase:
NA
Brief Summary
Lidocaine has been shown to blunt the cardiovascular response to endotracheal intubation. The incidence of hypertension, tachycardia and dysrhythmias due to laryngoscopy may be increased in patients t...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- reason for rapid sequence induction (emergency, reflux),
- ASA I-II,
- no antihypertensive drugs,
- no antiarrhythmic drugs
- Exclusion Criteria :
Exclusion
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2011
Estimated Enrollment :
76 Patients enrolled
Trial Details
Trial ID
NCT01238718
Start Date
October 1 2008
End Date
July 1 2011
Last Update
August 24 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aretaieio Hospital, University of Athens
Athens, Attica, Greece, 11528